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Abstract
Background: Although proton radiotherapy is a promising new approach for cancer patients, functional
interference is a concern for patients with implantable cardioverter defibrillators (ICDs). The purpose of this study
was to clarify the influence of secondary neutrons induced by proton radiotherapy on ICDs.
Methods: The experimental set-up simulated proton radiotherapy for a patient with an ICD. Four new ICDs were
placed 0.3 cm laterally and 3 cm distally outside the radiation field in order to evaluate the influence of secondary
neutrons. The cumulative in-field radiation dose was 107 Gy over 10 sessions of irradiation with a dose rate of 2
Gy/min and a field size of 10 × 10 cm
2. After each radiation fraction, interference with the ICD by the therapy was
analyzed by an ICD programmer. The dose distributions of secondary neutrons were estimated by Monte-Carlo
simulation.
Results: The frequency of the power-on reset, the most serious soft error where the programmed pacing mode
changes temporarily to a safety back-up mode, was 1 per approximately 50 Gy. The total number of soft errors
logged in all devices was 29, which was a rate of 1 soft error per approximately 15 Gy. No permanent device
malfunctions were detected. The calculated dose of secondary neutrons per 1 Gy proton dose in the phantom was
approximately 1.3-8.9 mSv/Gy.
Conclusions: With the present experimental settings, the probability was approximately 1 power-on reset per 50
Gy, which was below the dose level (60-80 Gy) generally used in proton radiotherapy. Further quantitative analysis
in various settings is needed to establish guidelines regarding proton radiotherapy for cancer patients with ICDs.
Keywords: Proton radiotherapy, Secondary neutrons, Implantable cardioverter defibrillator, Soft error, Monte-Carlo
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Background
Radiation therapy (RT) is a well-established modality for
cancer treatment. It has been estimated that about 25%
of all patients with cancer in Japan will require RT for
cancer in their lifetime [1]. This percentage is approxi-
mately double in the United States and European coun-
tries. Since the projected increase in the elderly
population of developed countries is the greatest in
Japan, RT is expected to play an increasingly important
role in Japan as well. Implantable cardioverter defibrilla-
tors (ICDs) are relatively large pacemakers that are also
able to deliver a high voltage shock in case of a life-
threatening ventricular tachycardia or ventricular fibril-
lation. They were first introduced in the early 1980s and
have become more common in patients at high risk for
sudden cardiac death. Random access memory (RAM),
which is currently used in practically all cardiac pulse
generators, is responsible for the high sensitivity of ICDs
to ionizing radiation [2,3]. The literature reports that
radiation therapy with high-dose ionizing radiation is
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in patients with ICDs with malignant disease [4,5].
Proton radiotherapy is a new mode of radiation ther-
apy that gives excellent dose distributions to the target.
Recently, the number of proton facilities has been
increasing worldwide. Direct proton beam irradiation on
a cardiac pulse generator can permanently destroy elec-
trical components, but this is seldom seen in the clinical
setting. Secondary neutrons represent a major fraction
of the radiation generated during proton radiotherapy
from proton-induced nuclear reactions both in beamline
components and in the patient’s body, so secondary
neutrons have been previously measured by various
detectors or estimated by Monte-Carlo simulation using
phantoms that are designed to represent human tissue
[6-10]. As a large proportion of malignant tumors and
selected benign diseases are treated with proton radio-
therapy, hazards linked to the effect of secondary neu-
trons on ICDs may cause clinical problems in ICD-
bearing patients. For such patients, it is still unclear
whether the use of proton radiotherapy is safe, and this
uncertainty reduces the number of tumor treatment
possibilities. Therefore, it is important to establish the
safety of delivering proton beams for patients with ICDs.
In the present study, ICDs in current clinical use were
tested with proton beam irradiation in order to assess
safety and ICD malfunction during proton beam
therapy.
Methods
ICDs
Four new ICDs (Marquis DR 7274, Medtronic, Minnea-
polis, MN) were used in the present experimental study.
These ICDs are indicated for ventricular anti-tachycar-
dia pacing and ventricular defibrillation for automated
treatment of life-threatening ventricular arrhythmias.
The external shield of the ICD is titanium, and the ICD
is 36 mL in volume (68.3 × 50.8 × 13.7 mm
3)w i t ha
mass of 75 g. Parameters such as pacing mode and sen-
sing threshold are programmed telemetrically, detected
abnormalities are automatically recorded, and serious
errors are recorded and alerted to with a sound. Prior to
the experiments, all ICDs had not been previously
exposed to radiation and were programmed to normal
settings with detection and therapies set to “off” in
order to avoid unexpected discharge.
Types of errors observed in the ICDs
Malfunctions of the ICDs used in the present experi-
ment were divided into four types, and are summarized
in Table 1. Hard errors, the most serious type, cause a
permanent stop in pulse generation. In the case of a
hard error, recovery is mostly incomplete, and the
device cannot be used reliably thereafter and must be
replaced. A soft error is also known as single event
upset (SEU), and soft errors were classified into three
types. Power-on reset (POR), the most critical soft error,
indicates accidental overwriting of important and pro-
tected device data that are essential for set-up of the
pacing function and arrhythmia detection. In this condi-
tion, the pacing mode changes temporarily to the safety
mode. Recovery may occur after the ICD is repro-
grammed. A partial electrical reset (PER) and a POR
both interfere with protected RAM data and cause the
alarm to sound. However, PER does not create a change
in the pacing mode or rate, because in the case of a
PER the position of the overwritten data in the RAM
does not overlap with the position in the RAM for
pacing mode or arrhythmia detection settings. Minor
errors cannot be detected by the programmer directly;
they are revealed only by analysis of the device’sd a t a
log.
After completion of each course of irradiation, ICD
parameters such as pacing mode and pulse rate were
analyzed by the programmer in-house. Data logs from
the ICDs were sent to the manufacturer for more
detailed analysis.
Proton radiotherapy equipment
Proton beams of 200 MeV (a spread in energy of s =
0.8 MeV) generated by a synchrotron with a linear
accelerator (PROBEAT; Hitachi, Tokyo, Japan) at the
Proton Medical Research Center (PMRC), University of
Tsukuba were used in the present study.
The proton radiotherapy system in the treatment
room consisted of an isocentrically rotating gantry
equipped with a biplane digital radiography unit and a
treatment couch. The proton irradiation method applied
at PMRC is the passive scattering method. Proton
beams were spread out and shaped with a ridge filter,
double-scatterer, multileaf collimators, and a custom-
made bolus that covered the target volume (Figure 1).
The patient bolus, which is normally mounted at the
shield ring, was not considered in this work.
Experimental settings
Figure 2 shows the experimental set-up of proton irra-
diation to the phantom with ICDs. As predicted from
previous clinical data, the frequency of soft errors was
very low [11].
Therefore, four ICDs were set on the back surfaces of
a water phantom (external dimension: 24 × 24 × 24
cm
3) in order to raise the probability of the occurrence
of soft errors. Proton beams entered the lateral side of
the phantom, and the distal end of the spread-out Bragg
peak (SOBP) was 3 cm in front of and 0.3 cm inside of
the ICDs. In other words, the devices were placed out-
side the field of direct and secondary proton beams in
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ary neutrons on the ICDs. Moreover, in order to provide
backscatter conditions, a 20-mm-thick acrylic plastic
board was placed behind the devices [12]. The dose rate
was 2 Gy/min and the field size was 10 × 10 cm
2.T h e
SOBP was 6 cm in length. A total of 107 Gy was deliv-
ered in 10 sessions of irradiation at the SOBP center,
and ranged from 2 to 20 Gy in one session. The ICDs
were monitored during proton beam irradiation in order
to detect the alarm sound that is produced by the device
to notify the occurrence of serious soft errors.
Dose distributions of secondary neutrons
Neutrons were classified according to their kinetic
energy as thermal (E < 0.5 eV), epithermal (0.5 eV<E <
10 keV) or fast (E > 10 keV). Dose distributions of total
secondary neutrons were estimated by numerical simu-
lation with the Monte-Carlo method utilizing the parti-
c l ea n dh e a v yi o nt r a n s p o r tc o d es y s t e m( P H I T S )
developed by the Japan Atomic Energy Agency: JAEA,
Japan. Details of the distribution of secondary neutrons
have been previously described [13,14].
Results
Table 1 shows the numbers and types of errors observed
in the present experiment. In POR, the ICDs presented
sudden complete failures, and reverted back to initial
factory-programmed settings. Additionally, the pacing
rate changed to 65 beats/min, which was not a manually
programmable rate. PERs or minor errors did not influ-
ence the function of the ICDs after completion of treat-
ment. After a POR, the ICDs functioned normally after
reprogramming.
Telemetry analysis by the programmer in-house after
completion of each course of irradiation revealed soft
errors in 13 of 40 courses of irradiation (Table 1).
According to detailed analysis of data logs in the ICDs,
multiple errors occurred in 4 courses during 1 course of
irradiation (POR + PER in 2, PER + a minor error in 1, 3
minor errors in 1) (Table 1). The frequency of POR was
approximately 1 per 50 Gy. The total number of critical
and minor soft errors was 29, for a rate of approximately
Table 1 Type, description and total number of ICD errors caused by the secondary neutron from 107 Gy proton beam
irradiation for each of four ICDs (Marquis DR 7274, Medtronic, Minneapolis, MN)
Type of
error
Explanation Change in
frequency and
pulse width
Alarm is
sounded
ICD
reprogramming
Number of sessions
detected by the
programmer
Number of errors
revealed by analysis of
the ICD data logs
Hard error The ICDs stop generating pulses
permanently.
Yes No Impossible 0 0
Soft error 13 29
Power-
on reset
The ICDs present sudden
complete failure and switch over
to the safety backup mode.
Yes Yes Necessary 8 8
Partial
electrical
reset
The ICDs show no change in
mode of pacing.
No Yes Unnecessary 5 7
Minor
error
The ICDs show no change in
mode of pacing.
No No Unnecessary 0 14
Abbreviation: ICD = implantable cardioverter defibrillator
Figure 1 Schematic of the proton beam delivery system.
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unpredictable and random from the start to the end of
the irradiation, and the frequency of the errors did not
increase with accumulated irradiation dose. Hard errors
were not observed in this experimental study, and the
ICDs in the initial factory-programmed settings retained
sensitivity of detecting arrhythmia and continued to gen-
erate pulses.
Figures 3 and 4 show the results of predicted dose as
determined by the Monte-Carlo calculation. The esti-
mated dose of secondary neutrons per 1 Gy proton dose
was approximately 2.7 mSv/Gy for the ICDs, and was
approximately 1.3-8.9 mSv/Gy in the phantom. The
gamma-ray dose per 1 Gy proton dose in the phantom
was approximately 0.11-0.45 mGy/Gy, and the ratio of
the gamma-ray dose at the beam central axis was about
5% of the total secondary radiation dose.
Discussion
Recently, some authors have reported a damaging effect
of therapeutic radiation on cardiac pulse generators
[4,5,15]. It is well known that ionizing radiation can
interfere with RAM in cardiac pulse generators. Recom-
mendations on the management of patients with cardiac
pulse generators undergoing radiotherapy are based on
limited studies mostly involving pacemakers [16,17].
The American Association of Physicists in Medicine
(AAPM) has published a review of contemporary cardiac
pacemaker failure due to radiation damage [3]. The
AAPM task group suggested that pacemakers should
not be placed in the direct therapy beam, and the maxi-
mum dose absorbed to the pacemaker should be below
2 Gy. In the present study, the gamma-ray dose in the
phantom was only about 0.11-0.45 mGy/Gy, which was
far below the dose of 2 Gy. Therefore, secondary
Figure 2 View of the experimental set-up of proton irradiation to the phantom with implantable cardioverter defibrillators (ICDs) on
the central axis of the proton beam. Four ICDs were placed on the contralateral side of the phantom. Proton beams entered the water
phantom laterally, and an acrylic plastic board was set behind the ICDs to provide backscatter conditions. Calculated spread-out Bragg peak
(SOBP) curves in water and experimental values are included.
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Figure 4 Results of predicted dose due to gamma-rays in the phantom determined by the Monte-Carlo calculation.
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on cardiac pulse generators. However, the AAPM
reports were based only on experience with pacemakers.
Kapa et al. reported that components of ICDs are more
vulnerable than pacemakers to the ionizing effects of
radiation [4]. Even when devices are kept out of the
direct radiation field during external-beam radiotherapy
using high-energy photons (e.g., ≥ 10 MV), device mal-
function can occur at minimal in-field dose levels. Lau
et al. reported a case of electrical reset of an ICD by
scattered irradiation from radiotherapy for a patient
with prostate cancer [18]. The device alarm went off
during external-beam radiotherapy to the pelvis using
23 MV photons. Secondary neutrons could have been
the cause of device malfunction in that report. Raitt et
al. reported the influence of fast neutron radiotherapy
on a pacemaker lying outside the treatment field [19].
The very low estimated dose of 0.9 Gy received by the
pacemaker demonstrated the extreme sensitivity of inte-
grated circuits. Although fast neutron radiotherapy is
not commonly used because of its unacceptably high
incidence of late morbidity, questions have been raised
concerning secondary neutrons produced by external-
beam radiotherapy using high-energy photons or by par-
ticle therapy.
In proton radiotherapy using the passive scattering
irradiation method, proton beams generate secondary
neutrons by the reaction with the collimator and several
other scattering components [6,20]. On the other hand,
Schneider et al. reported that the spot scanning techni-
que showed a dose advantage at a beam line of at least
10 times over the scatter foil technique [21]. In the
healthy tissues of their patient (in the non-treated
volume), the dose coming from neutrons was approxi-
mately 0.002-0.004 Sv per treatment Gy. These contri-
butions to the integral dose from neutrons are very low,
so they concluded that the dose deposited by secondary
neutrons during proton radiotherapy using the spot
scanning technique can be neglected in the treatment
region. However, proton beams also generate secondary
neutrons and photons by the reaction with several ele-
ments that form human body tissue. The internal inci-
dental dose around the center at deeper situated regions
accounted for about 60% to 80% of the total incidental
dose [14]. Therefore, in proton radiotherapy, it is impos-
sible to completely eliminate the influence of secondary
neutrons, even if shielding of external neutrons or active
scanning method are used.
Morávek et al. reported that the neutron contribution
to the dose behind the peak maximum was at least 3
orders smaller than the total dose at the peak maximum
[7]. Furthermore, it decreased exponentially with the
distance to the peak maximum. Therefore, they con-
cluded that its influence on the dose distribution is
m a r g i n a l .H o w e v e r ,i ts h o u l db ep o i n t e do u tt h a tt h e i r
work refers only to the physical dose and does not take
into account the influence on ICDs. To date, there have
been few studies of the interactions between ICDs and
secondary neutrons from proton radiotherapy. We pre-
viously reported that changes in heart rate occurred in 2
of 8 cancer patients with pacemakers who received pro-
ton radiotherapy in our facility [11]. Potential hazards of
proton beam irradiation for patients using the new gen-
eration of cardiac pulse generators with digital circuitry
are not yet well known. However, in order to keep open
as many options for cancer treatment as possible, the
judgment of contraindication of proton radiotherapy for
cancer patients with cardiac pulse generators should be
made carefully. To assess the safety and influence of
proton radiotherapy on ICDs, the present experimental
study was conducted. To our knowledge, this is the first
report on the influence of secondary neutrons generated
by proton radiotherapy on ICDs. Devices failed at the
rate of approximately 1 failure per 15 Gy, which is well
below the dose level (60-80 Gy) generally used in proton
radiotherapy. The probability of a soft error caused by
secondary neutrons induced by proton radiotherapy on
ICDs is very small, but it is an inevitable and unpredict-
able phenomenon. Rodriguez et al. reported on radia-
tion-induced effects in multi-programmable pacemakers
and ICDs [22]. Pacemaker malfunction induced by
ionizing-radiation exposure is unpredictable, because
these effects can occur in multiple locations in comple-
mentary metal-oxide semiconductor (CMOS) and do so
at random. Therefore, errors could potentially be
observed even at the minimal delivered dose, and relo-
cation of the device out of the radiation field is not
enough to prevent the occurrence of soft errors. Minor
errors which cannot be detected by the programmer
directly were often observed, suggesting that the device
could be damaged by secondary neutrons even if the
device malfunction is not apparent. Hard errors of the
ICDs were not observed in the present study, and the
devices in their initially programmed settings always
kept their sensitivity and generating pulses. Further
investigation is needed to clarify whether the total
cumulative radiation dose to the device results in an
increased likelihood of soft errors, and how much the
ratio of fast or thermal neutrons contributes to the
causes of soft error.
The experimental findings of the present study have
resulted in the recommendation in our department for
the use of this new cancer treatment modality for
patients with cardiac pulse generators. It is essential that
patients be monitored carefully during the course of
treatment and that the pacing mode and rate be moni-
tored after completion of irradiation in accordance with
the degree of dependence on the cardiac pulse
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sion, the device should be interrogated in order to find
all abnormalities. If possible, pre-treatment involving
experimental evaluation for each device is preferable,
because the effects of secondary neutrons varied
between the devices.
It should be pointed out that the measurements in the
present study were performed under a limited set of
standard physical conditions. To clarify how the deliv-
ered dose and position of the device influence the func-
tion of ICDs, further corrections are necessary for the
standard geometry in which patients with cancer are
irradiated in the clinical setting. In addition, the same
experimental irradiation should be tested in other facil-
ities with either equipment for particle therapy or with
linear accelerators with a capacity of over 10 MV X-ray
output. Furthermore, therapeutic guidelines concerning
the safe use of proton radiotherapy for patients bearing
cardiac pulse generators are needed.
Conclusions
Soft errors caused by secondary neutrons induced by
proton radiotherapy on ICDs are rare, but are an inevi-
table and unpredictable phenomenon. Although the pre-
sent study was performed under a limited set of clinical
conditions, the calculated dose of secondary neutrons
per 1 Gy proton dose was approximately 2.7 mSv/Gy to
the ICDs, and was approximately 1.3-8.9 mSv/Gy to the
phantom. Approximately 1 power-on reset occurred per
50 Gy, which was below the dose level (60-80 Gy) gen-
erally used in proton radiotherapy. Further quantitative
analysis in various settings is needed to establish guide-
lines regarding proton radiotherapy for cancer patients
with ICDs.
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